Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: Results from the US intergroup phase III trial E2997 Academic Article uri icon

Overview

MeSH Major

  • Leukemia, Lymphocytic, Chronic, B-Cell

abstract

  • These results support the use of interphase cytogenetic analysis, but not IgVH, CD38 expression, or ZAP-70 status, to predict outcome of FL-based chemotherapy. Patients with high-risk cytogenetic features should be considered for alternative therapies.

publication date

  • March 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.08.3089

PubMed ID

  • 17283363

Additional Document Info

start page

  • 799

end page

  • 804

volume

  • 25

number

  • 7